Finance

Lists
002873:SHE
Guiyang Xintian Pharmaceutical Co Ltd
CN¥8.18
-0.61%
(-0.050) 1D
Oct 15, 11:14:03 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002873...
Open
CN¥8.15
High
CN¥8.24
Low
CN¥8.07
Mkt. cap
2.06B
Avg. vol.
4.99M
Volume
3.05M
Dividend
0.37%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
279.28
52-wk high
CN¥13.09
52-wk low
CN¥7.04
EPS
CN¥0.03
Shares outstanding
244.10M
No. of employees
1K
Open
CN¥8.15
High
CN¥8.24
Low
CN¥8.07
Mkt. cap
2.06B
Avg. vol.
4.99M
Volume
3.05M
Dividend
0.37%
Quarterly dividend
CN¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
279.28
52-wk high
CN¥13.09
52-wk low
CN¥7.04
EPS
CN¥0.03
Shares outstanding
244.10M
No. of employees
1K
News stories
From web sources and news partners
About Guiyang Xintian Pharmaceutical Co Ltd
CEO-
Employees1.39K
FoundedAug 11, 1995
Headquarters-
SectorPharmaceutical industry
Websitegyxtyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
200.35M
191.09M
178.61M
153.22M
Cost of goods sold
54.09M
59.09M
49.13M
42.43M
Cost of revenue
54.09M
59.09M
49.13M
42.43M
Research and development expenses
12.03M
10.41M
9.30M
11.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
114.04M
125.40M
106.18M
92.88M
Operating expense
130.34M
137.34M
118.71M
105.01M
Total operating expenses
184.43M
196.43M
167.84M
147.44M
Operating income
15.92M
-5.35M
10.77M
5.77M
Other non operating income
-215.68K
505.88K
-40.98K
-495.16K
EBT including unusual items
10.40M
-6.90M
5.25M
2.96M
EBT excluding unusual items
11.83M
-9.94M
6.33M
1.11M
Income tax expense
-13.00K
167.36K
1.75M
1.60M
Effective tax rate
-0.12%
-2.42%
33.37%
53.89%
Other operating expenses
5.16M
1.56M
3.83M
2.23M
Net income
10.41M
-7.07M
3.50M
1.37M
Net profit margin
5.20%
-3.70%
1.96%
0.89%
Earnings per share
-
-
-
-
Interest and investment income
84.26K
124.27K
95.66K
192.47K
Interest expense
-3.96M
-5.23M
-4.50M
-4.36M
Net interest expenses
-3.88M
-5.10M
-4.40M
-4.17M
Depreciation and amortization charges
-
-
-
-
EBITDA
23.68M
2.87M
18.99M
14.09M
Gain or loss from assets sale
-845.41K
781.86K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps